News

Search:  

Regulatory Update | 9 May 2012

European Commission: Consultation on Stakeholder Participation In HTA Network

0 Likes

The European Commission is requesting input from stakeholders, including drug and device companies, as to “how the consultation with stakeholders in the Health Technology Assessment (HTA) network’s [Read More...]


Regulatory Update | 27 April 2012

EC: SCENIHR Issues Memorandum on Europe’s Scientific Risk Assessment Process

0 Likes

A memorandum issued by the European Commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) is intended to provide transparency to stakeholders on the Committee risk [Read More...]


Latest News | 2 March 2012

EC Proposes Streamlining Pricing, Reimbursement Decisions

0 Likes

The European Commission (EC) wants drugs to reach the market faster and is proposing changes to the pricing and reimbursement process.In a report by PMLive Intelligence Online, revisions to the [Read More...]


Latest News | 3 February 2012

EC Investigation of PIP Implants Inconclusive, Calls for Further Study

0 Likes

A European Commission (EC) study of the breast implant products manufactured by French company Poly Implant Prothese (PIP) has come to inconclusive results regarding the rupture rate of PIP’s breast [Read More...]